Discover how a single daily pill is transforming hypertension treatment. Simplified care and better results are reshaping patient health globally. Skip to content ...

M ore than seven million people are living with cardiovascular disease in the UK, with 100,000 heart attacks and over 100,000 strokes occurring annually. The NHS could prevent thousands of heart ...

The Gemini Study was a 14-week, open-label, non-comparative, office-based, multicenter trial to evaluate single-pill therapy in the treatment of concomitant hypertension and dyslipidemia. In ...

Widaplik is a single tablet, triple combination therapy for hypertension that is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved ...